Evolution of the Average Target: JPMorgan Chase & Co.

Evolution of the Target Price: JPMorgan Chase & Co.

Changes in Analyst Recommendations: JPMorgan Chase & Co.

c9166938321c6a63e1943.9Ldw2wirSjUPPGw2KjkhLBstUcCj_MSwP3KyW2d6js8.teQGi2XRCVZ_chhEGAkSaiN9ArfrhLboCTzYKQ8T57if2DmQQds7fGMJHw~61fdc19c7211e76b61db8ff85ef1a254
Mar. 04 Baird Adjusts PT on JPMorgan Chase & Co. to $290 From $280, Maintains Neutral Rating MT
Mar. 04 Oil seen elevated as Hormuz risks intensify amid Iran conflict, analysts say RE
Feb. 26 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
Feb. 25 JP Morgan raises long-term gold price forecast to $4,500 RE
Feb. 25 Truist Securities Adjusts Price Target on JPMorgan Chase to $330 From $334 MT
Feb. 17 JPMORGAN : Receives a Buy rating from Barclays ZD
Feb. 13 JPMORGAN : Gets a Buy rating from Barclays ZD
Feb. 11 Top Midday Decliners MT
Feb. 06 HSBC Upgrades JPMorgan Chase & Co. to Hold From Reduce, Adjusts PT to $319 From $296 MT
Feb. 04 Morgan Stanley raises near-term Brent forecasts, WFII lowers prediction RE
Feb. 04 Morgan Stanley raises near-term Brent forecasts RE
Feb. 03 Baird Upgrades JPMorgan Chase to Neutral From Underperform, Keeps Price Target at $280 MT
Jan. 27 JPMorgan Chase & Co's long position in Country Garden decreases to 4.7% on Jan 22 - HKEX RE
Jan. 26 Goldman Sachs Adjusts Price Target on JPMorgan Chase & Co. to $397 From $386, Maintains Buy Rating MT
Jan. 22 U.S. fintech could gain as Trump pushes affordability agenda, Citi says RE
Jan. 14 JPMORGAN : DZ Bank reiterates its Neutral rating ZD
Jan. 14 CICC Initiates JPMorgan Chase & Co. at Outperform With $355 Price Target MT
Jan. 14 Piper Sandler Adjusts PT on JPMorgan Chase & Co. to $345 From $336, Maintains Overweight Rating MT
Jan. 14 Baird Adjusts PT on JPMorgan Chase & Co. to $280 From $260, Maintains Underperform Rating MT
Jan. 14 JPMORGAN : Barclays maintains a Buy rating ZD
Jan. 13 Piper Sandler Adjusts Price Target on JPMorgan Chase to $345 From $336, Maintains Overweight Rating MT
Jan. 13 JPMORGAN : Receives a Buy rating from Barclays ZD
Jan. 12 JPMORGAN : Buy rating from Barclays ZD
Jan. 09 S&P 500 Climbs in First Full Week of 2026, Hits New Highs MT
Jan. 09 BNP Paribas Rises as JPMorgan Turns More Optimistic Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.41%
+28.06%
+17.96%
-0.81%
+20.81%
+29.44%
+22.35%
+9.11%
-25.82%
+12.13%
Average +13.26%
Weighted average by Cap. +15.26%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
287.52USD
Average target price
344.78USD
Spread / Average Target
+19.92%
High Price Target
400.00USD
Spread / Highest target
+39.12%
Low Price Target
289.00USD
Spread / Lowest Target
+0.51%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
Truist Securities
BARCLAYS Jason Goldberg
HSBC
Goldman Sachs
CICC Research
Piper Sandler
DZ BANK Philipp Häßler
BofA Securities
Evercore ISI
Deutsche Bank Securities
TD Cowen
JPMorgan Chase
RBC Anke Reingen
Autonomous Research
Daiwa Securities
Wells Fargo Securities
Keefe Bruyette & Woods
RBC Capital Markets
Morgan Stanley
Phillip Securities
Wolfe Research
KGI Securities
Argus
UBS
Seaport Global Securities
Citigroup
DBS Bank
Stifel Nicolaus
DEUTSCHE BANK RESEARCH Matt O'Connor
Oppenheimer
JEFFERIES Daniel Fannon
Jefferies & Co.
Redburn Atlantic
BMO Capital
Keefe, Bruyette & Woods
Atlantic Equities
Credit Suisse
Societe Generale
Odeon Capital
Morningstar
Berenberg Bank
BERENBERG Peter Richardson
Zacks Investment Research
DA Davidson
DEUTSCHE BANK Matt O'Connor
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
287.52USD
Average target price
344.78USD
Spread / Average Target
+19.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. JPM Stock
  4. Consensus JPMorgan Chase & Co.
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW